Harry R Maxon, Iii

Title: Innovations of Harry R Maxon, III

Introduction

Harry R Maxon, III is a notable inventor based in Terrace Park, Ohio. He has made significant contributions to the field of medical imaging and radiopharmaceuticals. With a total of two patents to his name, his work focuses on innovative methods for detecting neoplastic tissue.

Latest Patents

Maxon's latest patents include the development of a radiolabeled dihematoporphyrin ether. This compound is useful in providing a non-invasive nuclear scintillation image. The dihematoporphyrin ether localizes in neoplastic tissue, allowing for effective imaging and recording of its location. Additionally, when the labeling agent has an adequate component of particulate radiation, this compound can serve as both a therapeutic agent and a diagnostic imaging agent. His other patent involves a procedure for isolating and purifying radioactive ligated rhenium, which is essential for preparing a sterile pyrogen-free radiopharmaceutical.

Career Highlights

Maxon is affiliated with the University of Cincinnati, where he continues to advance his research in radiopharmaceuticals. His work has implications for improving cancer diagnostics and treatment, showcasing his commitment to enhancing medical technology.

Collaborations

He has collaborated with notable colleagues, including Edward A Deutsch and Karen F Libson, contributing to the advancement of their shared research goals.

Conclusion

Harry R Maxon, III's innovative work in the field of radiopharmaceuticals highlights his significant contributions to medical imaging and cancer treatment. His patents reflect a dedication to improving diagnostic methods and therapeutic options for neoplastic tissue.